The women’s health market continues to see unprecedented competition for transactions, write attorneys with McGuireWoods. These trends, along with COVID-19-specific transaction considerations, create interesting dynamics for investors and providers in the women’s health and fertility subsectors, as discussed during a webinar, “Key Transaction and Regulatory Considerations for Women’s Health and Fertility,” presented by McGuireWoods healthcare lawyers Kayla Marty and Erin Dine. Read more.
Transaction and Regulatory Concerns for Women’s Health and Fertility: Five Key Takeaways
